Johnson & Johnson (JNJ) free cash flow

Free cash flow · fiscal 2025
$19.31B

Johnson & Johnson (JNJ) generated free cash flow of $19.31B in fiscal 2025 (the year ended December 31, 2025). That is 6.9% higher than the $18.06B of fiscal 2024. Figures as of 18 Nov 2026, 12:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$19.31B
Change on fiscal 2024
+6.9%
Highest on record
$20.19Bfiscal 2021
Lowest on record
$11.41Bfiscal 2012
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Johnson & Johnson free cash flow, in more detail

Across the 19 fiscal years on record (2007–2025), the highest was $20.19B in fiscal 2021 and the lowest $11.41B in fiscal 2012.

History · 19 fiscal years

Free cash flow by fiscal year

Johnson & Johnson free cash flow, year by year

Johnson & Johnson (JNJ) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$19.31B 6.9% up
2024$18.06B 1.6% up
2023$17.78B 3.5% up
2022$17.19B—
2022$19.76B 2.1% down
2021$20.19B—
2019$19.92B 7.5% up
2018$18.53B 4.2% up
2017$17.78B—
2017$15.54B 3.5% down
2016$16.11B—
2014$15.00B 8.5% up
2013$13.82B 10.9% up
2012$12.46B—
2012$11.41B 18.5% down
2011$14.00B 1.4% down
2010$14.21B—
2008$11.91B 1.4% down
2007$12.08B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Johnson & Johnson and comparable companies
CompanyFree cash flowFiscal year
Johnson & Johnson JNJ$19.31B2025
AbbVie ABBV$17.82B2025
Merck & Co MRK$12.36B2025
UnitedHealth Group UNH$16.08B2025
Novartis NVS$15.24B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JNJ

Johnson & Johnson, figure by figure

Johnson & Johnson (JNJ) overview: price, valuation and scorecardAll health care companies by market value

Johnson & Johnson free cash flow: questions and answers

What is Johnson & Johnson's free cash flow?

Johnson & Johnson (JNJ) generated free cash flow of $19.31B in fiscal 2025 (the year ended December 31, 2025). That is 6.9% higher than the $18.06B of fiscal 2024.

What are the highest and lowest free cash flow figures on record for Johnson & Johnson?

Across the 19 fiscal years on record (2007–2025), the highest was $20.19B in fiscal 2021 and the lowest $11.41B in fiscal 2012.

How is Johnson & Johnson's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Johnson & Johnson it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Johnson & Johnson (JNJ) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.